Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refining the Surgical Necrotizing Enterocolitis Protocol: Impact of Clinical Factors on Laparotomy Risk.

The Journal of surgical research·2026
Same author

Invited Commentary: The Martin Memorial Lecture: Returning to the Oath in an Uncertain Time.

Journal of the American College of Surgeons·2026
Same author

The Association for Academic Surgery: The Gateway to Transformative Leadership in American Surgery.

The Journal of surgical research·2024
Same author

The Story of Dr. Asa G. Yancey and Surgical Innovation in the Face of Discrimination.

The Journal of surgical research·2024
Same author

Surgery and Surgical Training Before Graduate Medical Education: A Blue Ribbon Committee II, Medical Student Education Subcommittee Report.

Annals of surgery·2024
Same author

FXR deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammation.

American journal of physiology. Gastrointestinal and liver physiology·2024
Same journal

Management of Common Bile Duct Stones: Current Approaches and Evolving Endoscopic Strategies.

Current gastroenterology reports·2026
Same journal

Solitary Rectal Ulcer Syndrome Revisited: A Comprehensive Narrative Review.

Current gastroenterology reports·2026
Same journal

The Microbiome and Esophageal Disease: Where Are We Now?

Current gastroenterology reports·2026
Same journal

Fermented Durian Tempoyak as a Source of Probiotics for Colorectal Cancer Prevention through Gut Microbiome Modulation.

Current gastroenterology reports·2026
Same journal

A Practical Guide to Incorporating Novel Barrett's Screening/Surveillance Tools into Clinical Practice.

Current gastroenterology reports·2026
Same journal

The Role of Endoscopic Ultrasound in the Diagnosis and Management of Congenital Gastrointestinal and Pancreaticobiliary Conditions.

Current gastroenterology reports·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
05:45

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5

Published on: April 26, 2019

Recent developments in Hirschsprung's-associated enterocolitis.

Elizabeth M Pontarelli1, Henri R Ford, Christopher P Gayer

  • 1Children's Hospital Los Angeles, 4650 Sunset Blvd MS#100, Los Angeles, CA 90027, USA.

Current Gastroenterology Reports
|July 17, 2013
PubMed
Summary
This summary is machine-generated.

Hirschsprung's-associated enterocolitis (HAEC) poses significant risks for patients with Hirschsprung's disease (HD). Research is advancing classification systems, exploring the role of gut microbiota, and investigating links to inflammatory bowel disease to improve patient outcomes.

More Related Videos

Immunostaining to Visualize Murine Enteric Nervous System Development
07:54

Immunostaining to Visualize Murine Enteric Nervous System Development

Published on: April 29, 2015

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Related Experiment Videos

Last Updated: May 9, 2026

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
05:45

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5

Published on: April 26, 2019

Immunostaining to Visualize Murine Enteric Nervous System Development
07:54

Immunostaining to Visualize Murine Enteric Nervous System Development

Published on: April 29, 2015

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Area of Science:

  • Pediatric surgery
  • Gastroenterology
  • Genetics

Background:

  • Hirschsprung's-associated enterocolitis (HAEC) is a major complication of Hirschsprung's disease (HD).
  • Current understanding of HAEC pathogenesis, including the role of intestinal microbiota, is incomplete.
  • Existing treatments and their efficacy in preventing HAEC require further investigation.

Purpose of the Study:

  • To highlight the need for standardized clinical and histologic classification systems for HAEC.
  • To discuss the potential role of the intestinal microbiota in the development of HD and HAEC.
  • To review the controversial benefits of adjunctive therapies for HAEC prevention.
  • To present new findings on the association between HAEC and inflammatory bowel disease (IBD).

Main Methods:

  • Review of existing literature and clinical data.
  • Analysis of emerging evidence on disease pathogenesis.
  • Evaluation of controversial therapeutic approaches.
  • Presentation of new clinical associations.

Main Results:

  • New classification systems are proposed to enhance consistency in reporting HAEC outcomes.
  • The intestinal microbiota is implicated as a potential factor in HD and HAEC development.
  • The efficacy of adjunctive therapies like anal dilations and botulinum toxin for HAEC prevention remains debated.
  • A novel association between HAEC and inflammatory bowel disease has been identified.

Conclusions:

  • Standardized HAEC classification is crucial for comparative outcome analysis.
  • Further research into the gut microbiota's role in HAEC pathogenesis is warranted.
  • The utility of adjunctive therapies requires further clinical validation.
  • The identified link between HAEC and IBD necessitates further genetic investigation.